Cargando…

Metastatic recurrence after complete resection of colorectal liver metastases: impact of surgery and chemotherapy on survival

PURPOSE: Surgery is the standard of care for resectable colorectal liver metastases (CRC-LM). Unfortunately, 60 % of patients develop secondary metastatic recurrence (SMR) after R0-resection of CRC-LM. We investigated the impact of surgical re-intervention and chemotherapy (Ctx) on survival in a con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Homayounfar, K., Bleckmann, A., Conradi, L. C., Sprenger, T., Lorf, T., Niessner, M., Sahlmann, C. O., Meller, J., Liersch, T., Ghadimi, B. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712136/ https://www.ncbi.nlm.nih.gov/pubmed/23371333 http://dx.doi.org/10.1007/s00384-013-1648-2

Ejemplares similares

Bilobar spreading of colorectal liver metastases does not significantly affect survival after R0 resection in the era of interdisciplinary multimodal treatment
por: Homayounfar, K., et al.
Publicado: (2012)

Multimodal treatment options for bilobar colorectal liver metastases
por: Homayounfar, Kia, et al.
Publicado: (2010)

Two-stage hepatectomy (R0) with portal vein ligation—towards curing patients with extended bilobular colorectal liver metastases
por: Homayounfar, K., et al.
Publicado: (2008)

HER-2 and HER-3 expression in liver metastases of patients with colorectal cancer
por: Styczen, Hanna, et al.
Publicado: (2015)

Thymidylate Synthase as a Prognostic Biomarker for Locally Advanced Rectal Cancer after multimodal Treatment
por: Conradi, Lena-Christin, et al.
Publicado: (2011)

The Prognostic Value of Tyrosine Kinase SRC Expression in Locally Advanced Rectal Cancer
por: Rühlmann, Felix, et al.
Publicado: (2017)

Preoperative Chemoradiotherapy Does Not Necessarily Reduce Lymph Node Retrieval in Rectal Cancer Specimens—Results from a Prospective Evaluation with Extensive Pathological Work-up
por: Sprenger, Thilo, et al.
Publicado: (2009)

Distinct Chromosomal Profiles in Metastasizing and Non-Metastasizing Colorectal Carcinomas
por: Ghadimi, B. Michael, et al.
Publicado: (2006)

β-catenin-independent WNT signaling and Ki67 in contrast to the estrogen receptor status are prognostic and associated with poor prognosis in breast cancer liver metastases
por: Bleckmann, Annalen, et al.
Publicado: (2016)

Oxaliplatin-Induced Leukocytoclastic Vasculitis under Adjuvant Chemotherapy for Colorectal Cancer: Two Cases of a Rare Adverse Event
por: Quack, Henriette, et al.
Publicado: (2013)

Stage II/III rectal cancer with intermediate response to preoperative radiochemotherapy: Do we have indications for individual risk stratification?
por: Sprenger, Thilo, et al.
Publicado: (2010)

The utilization of multidisciplinary tumor boards (MDT) in clinical routine: results of a health care research study focusing on patients with metastasized colorectal cancer
por: Lowes, Markus, et al.
Publicado: (2017)

Resection of colorectal liver metastases following neoadjuvant chemotherapy
por: Chiappa, A, et al.
Publicado: (2007)

High-Throughput Profiling of Colorectal Cancer Liver Metastases Reveals Intra- and Inter-Patient Heterogeneity in the EGFR and WNT Pathways Associated with Clinical Outcome
por: Menck, Kerstin, et al.
Publicado: (2022)

Recurrence After Liver Resection of Colorectal Liver Metastases: Repeat Resection or Ablation Followed by Hepatic Arterial Infusion Pump Chemotherapy
por: Buisman, Florian E., et al.
Publicado: (2020)

Different Forms of Tumor Vascularization and Their Clinical Implications Focusing on Vessel Co-option in Colorectal Cancer Liver Metastases
por: Haas, Gwendolyn, et al.
Publicado: (2021)

Effect of Neoadjuvant Chemotherapy in Patients with Resectable Colorectal Liver Metastases
por: Zhu, Dexiang, et al.
Publicado: (2014)

Predictors of early recurrence after resection of colorectal liver metastases
por: Bhogal, Ricky Harminder, et al.
Publicado: (2015)

Peri-operative chemotherapy in the management of resectable colorectal cancer pulmonary metastases
por: Hawkes, Eliza A, et al.
Publicado: (2012)

Enhancing PSMA-uptake with androgen deprivation therapy – a new way to detect prostate cancer metastases?
por: Leitsmann, Conrad, et al.
Publicado: (2019)

Recurrence patterns predict survival after resection of colorectal liver metastases
por: Wong, Geoffrey Yuet Mun, et al.
Publicado: (2022)

FGFR3 mRNA overexpression defines a subset of oligometastatic colorectal cancers with worse prognosis
por: Fromme, Julia Elisabeth, et al.
Publicado: (2018)

Is neoadjuvant chemotherapy necessary for patients with initially resectable colorectal liver metastases in the era of effective chemotherapy?
por: Son, Sang-Yong, et al.
Publicado: (2011)

Molecular differences of angiogenic versus vessel co-opting colorectal cancer liver metastases at single-cell resolution
por: Fleischer, Johannes Robert, et al.
Publicado: (2023)

Safe liver resection following chemotherapy for colorectal metastases is a matter of timing
por: Welsh, F K S, et al.
Publicado: (2007)

Efficacy of laparoscopic liver resection in colorectal liver metastases and the influence of preoperative chemotherapy
por: Kubota, Yoshihisa, et al.
Publicado: (2014)

Optimal indication criteria for neoadjuvant chemotherapy in patients with resectable colorectal liver metastases
por: Ichida, Hirofumi, et al.
Publicado: (2019)

Multicentre study of perioperative versus adjuvant chemotherapy for resectable colorectal liver metastases
por: Allard, M.‐A., et al.
Publicado: (2019)

Surgery for colorectal liver metastases: the impact of resection margins on recurrence and overall survival
por: Angelsen, Jon-Helge, et al.
Publicado: (2014)

Molecular Cytogenetics: Genomic Imbalances in Colorectal Cancer and their Clinical Impact
por: Grade, Marian, et al.
Publicado: (2006)

Systematic Review With Network Meta-Analysis: Adjuvant Chemotherapy for Resected Colorectal Liver Metastases
por: Zhu, Gui-Qi, et al.
Publicado: (2015)

Prognostic value of circulating tumour cells for early recurrence after resection of colorectal liver metastases
por: Lalmahomed, Z S, et al.
Publicado: (2015)

Histopathologic factors affecting tumor recurrence after hepatic resection in colorectal liver metastases
por: Park, Min-Su, et al.
Publicado: (2014)

Liver resection for non-colorectal metastases
por: Schwarz, Christoph, et al.
Publicado: (2018)

Vertebral Column Metastases from an Esthesioneuroblastoma: Chemotherapy, Radiation, and Resection for Recurrence with 15-Year Followup
por: Shirzadi, Ali S., et al.
Publicado: (2013)

The mesopancreas is the primary site for R1 resection in pancreatic head cancer: relevance for clinical trials
por: Gaedcke, J., et al.
Publicado: (2009)

Combined targeting of HER-2 and HER-3 represents a promising therapeutic strategy in colorectal cancer
por: Conradi, Lena-Christin, et al.
Publicado: (2019)

Predictive factors for time to recurrence, treatment and post-recurrence survival in patients with initially resected colorectal liver metastases
por: Angelsen, Jon-Helge, et al.
Publicado: (2015)

Outcome of Microscopic Incomplete Resection (R1) of Colorectal Liver Metastases in the Era of Neoadjuvant Chemotherapy
por: Ayez, Ninos, et al.
Publicado: (2011)

A proposed new method for assessing the pathological response to chemotherapy in resected colorectal liver metastases
por: Sebagh, M, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_s66nt8cdb1jtpu0us5e3f60t93